KL1333 Clinical Trials

1 actively recruiting trial across 1 location

No change since June 2026

Pipeline

Phase 2: 1

Top Sponsors

Pharming Technologies B.V.1

Indications

Primary Mitochondrial Disease1
Diabetes1

Orange, California1 trial

Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease

University of California, Irvine - ALS & Neuromuscular Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.